课题基金 / 基金详情

Functional characterization and relevance of carnitine transporter OCTN2 to secondary carnitine deficiency.

Functional characterization and relevance of carnitine transporter OCTN2 to secondary carnitine deficiency.
肉碱转运蛋白 OCTN2 的功能特征及其与继发性肉碱缺乏症的相关性。
批准号:
11672212
负责人:
TAMAI Ikumi
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TAMAI Ikumi的其他基金

相似基金

相关文献

中文摘要
翻译
在本研究中,从人和小鼠中鉴定了新的Na^+依赖性肉碱/有机阳离子转运蛋白家族,OCTNs,并对其进行了功能表征。我们分别从人和小鼠中分离到2个和3个OCTN家族成员。octn存在于多种组织中,包括肾脏、心脏、骨骼肌和胎盘,以及几种人类来源的癌细胞系。通过免疫组化分析,小鼠肾小管上皮细胞的OCTNs通常定位于管腔膜。大多数人和小鼠的octn具有转运肉碱和有机阳离子四乙基铵(TEA)的多功能性。此外,钠离子是人类和小鼠OCTN1和2转运肉毒碱所必需的。在系统性肉毒碱缺乏症(SCD)表型小鼠模型中,发现OCTN2基因突变。此外,在人类SCD患者中发现了几种突变,表明OCTN2是生理上重要的肉毒碱转运蛋白。有趣的是,TEA转运与钠无关。此外,OCTN2转运多种阳离子药物,如奎尼丁、异拉帕米和放射线霉素d。此外,由于人类OCTN2的一个突变丧失了肉毒碱转运活性,但保留了TEA转运活性,这表明OCTN2对肉毒碱和有机阳离子具有不同的功能位点。因此,octn被认为是一种多功能转运体,可分别以钠离子依赖和独立的方式转运肉毒碱和有机阳离子,对有机阳离子药物和肉毒碱的处置具有重要意义。此外,由于通过OCTN2的肉毒碱转运受到多种化合物的抑制,包括有机阳离子、有机阴离子(如丙戊酸)和中性化合物(如皮质酮),预计药物诱导的继发性肉毒碱缺乏可能是由OCTN2的相互作用引起的。
英文摘要
In the present study, novel Na^+-dependent carnitine/organic cation transporter family, OCTNs from human and mouse were identified and functionally characterized. We isolated two and three members of OCTN family from human and mouse, respectively. OCTNs are present in various tissues, including kidney, heart, skeletal muscle and placenta strongly, and in several human-derived cancer cell lines. By immunohistochemical analysis in kidney, mouse OCTNs localized commonly in luminal membrane of tubular epithelial cells. Most of human and mouse OCTNs exhibited multifunctionality by transporting both of carnitine and organic cation, tetraethylammonium (TEA). Furthermore, sodium ions were essential for carnitine transport by human and mouse OCTN1 and 2. In systemic carnitine deficiency (SCD) phenotype mouse model, juvenile visceral steotosis (jvs) mouse, mutation in OCTN2 gene was found. Furthermore, several kinds of mutation in human SCD patients were found, demonstrating that OCTN2 is a physiologically important carnitine transporter. Interestingly, TEA transport was sodium independent. In addition, OCTNs transporterd various cationic drugs such as quinidine, verapamil, and actinomycin D.Furthermore, since one mutation of human OCTN2 lost carnitine transport activity but retained TEA transport activity, it was suggested that OCTN2 have differential functional sites for carnitine and organic cations. So, OCTNs are thought to be multifunctional transporters by transporting carnitine and organic cations by sodium ion dependent and independent manner, respectively, and would be important for disposition of organic cationic drugs as well as carnitine. Furthermore, since carnitine transport via OCTN2 is inhibited various compounds, including organic cations, organic anions such as valproic acid and neutral compound such as cortisole, it is anticipated that drug-induced secondary carnitine deficiency could be caused by interaction on OCTN2.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
K.Yokogawa: "Loss of mild-type carrier-mediated L-carnitine transport activity in hepatocytes of Juvenile viscernal steatosis mice"Hepatology. 30. 997-1001 (1999)
K.Yokokawa:“幼年内脏脂肪变性小鼠肝细胞中轻度载体介导的左旋肉碱转运活性的丧失”肝病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tamai,I.: "Molecular and functional characterization of carnitine/organic cation transporter family in mice"J.Biol, Chem.. 275・51. 40064-40072 (2000)
Tamai, I.:“小鼠肉毒碱/有机阳离子转运蛋白家族的分子和功能表征”J.Biol,Chem.. 275・51(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Yabuuchi: "Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transpot of organic cations"J. Pharmacol. Exp. Ther.. 289・2. 768-773 (1999)
H. Yabuuchi:“新型膜转运蛋白 OCTN1 介导有机阳离子的多特异性、双向和 pH 依赖性转运”J. Pharmacol. 289・2 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 23 条
    Application of Sandwich-cultured hepatocytes for analysis of drug-drug interaction on bile canalicular transporters
    • 批准号:
      23659076
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      TAMAI Ikumi
    • 依托单位:
    Clarification and evaluation of regulation mechanism of uric acid
    • 批准号:
      21390044
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2009
    • 负责人:
      TAMAI Ikumi
    • 依托单位:
    Species difference in hepatic disposition of organic anions
    Establishment of Novel Anti-Hormone Therapy of Breast Cancer based on the Inhibition of Uptake Transporter of Conjugated Estrogen by Cancer Cells.
    • 批准号:
      17390046
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.47万
    • 财政年份:
      2005
    • 负责人:
      TAMAI Ikumi
    • 依托单位:
    国内基金
    海外基金
    小立碗藓转录因子PpTF66调控离子通道PpSOT1在盐胁迫应答中的作用机制
    • 批准号:
      31970658
    • 项目类别:
      面上项目
    • 资助金额:
      52.0万元
    • 批准年份:
      2019
    • 负责人:
      何奕騉
    • 依托单位:
    肺炎支原体外排泵ABC Transporter在大环内酯类耐药中的作用机制研究
    • 批准号:
      81672062
    • 项目类别:
      面上项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2016
    • 负责人:
      孙红妹
    • 依托单位:
    PICK1对心脏局部交感神经递质的平衡调控机制研究
    • 批准号:
      31000472
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2010
    • 负责人:
      靳文英
    • 依托单位:
    低氧诱导因子(HIF)以及氧化还原系统(redox)与肿瘤多药耐药(MDR)的相互作用
    • 批准号:
      31070750
    • 项目类别:
      面上项目
    • 资助金额:
      34.0万元
    • 批准年份:
      2010
    • 负责人:
      周捷
    • 依托单位: